Association of interleukin-2, interleukin-21 and interleukin-23 with hyperlipidemia in pediatric type 1 diabetes

被引：0
|
作者：
Rehab G. Khalil
Adel Abdel-Moneim
Ahmed I. Yousef
Hanan Abdel-Rahman
Mohamed I. Zanaty
Amr El-Sayed
机构：
[1] Beni-Suef University,Immunology Division, Faculty of Science
[2] Beni-Suef University,Molecular Physiology Division, Faculty of Science
[3] Beni-Suef University,Biotechnology and Life Sciences Department, Faculty of Postgraduate Studies for Advanced Science
来源：
Molecular Biology Reports | 2021年 / 48卷
关键词：
Type1 diabetes mellitus; Interleukin-2; Interleukin-21; Interleukin-23; Lipid profile;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5421 / 5433
页数：12
相关论文
共 50 条
  • [21] INTERLEUKIN-1 AND INTERLEUKIN-2 IN CHRONIC TYPE-B HEPATITIS
    MINUK, GY
    LAFRENIERE, R
    GASTROENTEROLOGY, 1988, 94 (04) : 1094 - 1096
  • [22] Dual function of interleukin-23 Aptamer to suppress brain inflammation via attachment to macrophage stimulating 1 kinase and interleukin-23
    Sardou, Hossein Shandadi
    Jebali, Ali
    Iman, Maryam
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2020, 185
  • [23] Interleukin-23 Promotes Th17 Differentiation by Inhibiting T-bet and FoxP3 and Is Required for Elevation of Interleukin-22, but Not Interleukin-21, in Autoimmune Experimental Arthritis
    Mus, Adriana M. C.
    Cornelissen, Ferry
    Asmawidjaja, Patrick S.
    van Hamburg, Jan Piet
    Boon, Louis
    Hendriks, Rudi W.
    Lubberts, Erik
    ARTHRITIS AND RHEUMATISM, 2010, 62 (04): : 1043 - 1050
  • [24] INTERLEUKIN-2 PRODUCTION AND TYPE-I DIABETES
    DANCYGIER, H
    BERG, J
    CLASSEN, M
    NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (15): : 949 - 950
  • [25] Soluble interleukin-2 receptor in prediabetes, in overt diabetes type 1 and diabetes type 2
    Mianowska, B
    Bodalska-Lipinska, J
    Krokowski, M
    Chrul, S
    Wyka, K
    Lawnik, M
    Bodalski, J
    DIABETOLOGIA, 1999, 42 : A101 - A101
  • [26] Soluble interleukin-2 receptor alpha in preclinical type 1 diabetes
    Stephanie Krause
    Andreas Beyerlein
    Christiane Winkler
    Anita Gavrisan
    Christiane Kayser
    Ramona Puff
    Ezio Bonifacio
    Anette-Gabriele Ziegler
    Peter Achenbach
    Acta Diabetologica, 2014, 51 : 517 - 518
  • [27] Assessing the effectiveness of Interleukin-2 therapy in experimental type 1 diabetes
    Luo, Zhengkang
    Mejia-Cordova, Mariela
    Hamze, Nour
    Berggren, Elin
    Chopra, Saloni
    Safi, Bilal
    Blixt, Martin
    Sandler, Stellan
    Singh, Kailash
    ENDOCRINE, 2024, 85 (02) : 626 - 637
  • [28] Association of sarcopenia and expression of interleukin-23 in colorectal cancer survival
    Hu, Wan-Hsiang
    Chang, Ching-Di
    Liu, Ting-Ting
    Chen, Hong-Hwa
    Hsiao, Chang-Chun
    Kang, Hong-Yo
    Chuang, Jiin-Haur
    CLINICAL NUTRITION, 2021, 40 (10) : 5322 - 5326
  • [29] Increased production of interleukin-21, but not interleukin-17A, in the small intestine characterizes pediatric celiac disease
    van Leeuwen, M. A.
    Lindenbergh-Kortleve, D. J.
    Raatgeep, H. C.
    de Ruiter, L. F.
    de Krijger, R. R.
    Groeneweg, M.
    Escher, J. C.
    Samsom, J. N.
    MUCOSAL IMMUNOLOGY, 2013, 6 (06) : 1202 - 1213
  • [30] Soluble interleukin-2 receptor alpha in preclinical type 1 diabetes
    Krause, Stephanie
    Beyerlein, Andreas
    Winkler, Christiane
    Gavrisan, Anita
    Kayser, Christiane
    Puff, Ramona
    Bonifacio, Ezio
    Ziegler, Anette-Gabriele
    Achenbach, Peter
    ACTA DIABETOLOGICA, 2014, 51 (03) : 517 - 518
12345